ABI3BP is a prognosis biomarker related with clinicopathological features and immunity infiltration of lung tumor

Background: The primary factor of cancer mortality is lung tumor. ABI3BP gene encodes an extracellular matrix bind protein associated to multiplication and derivation. However, the prognosis score of ABI3BP for lung tumor and its relation with immunity cellular infiltration for lung tumor have not been reported. Methods: Public repository systems (Timer, GEPIA, TCGA, HPA) were utilized to explore expression of ABI3BP for lung tumor, and explored the relation of ABI3BP and clinicopathological parameters. TCGA information set was utilized for cox analysis for data with one or more variables of ABI3BP for lung tumor. STRING was utilized to explore ABI3BP regulatory networks. GO/KEGG enrichment analysis as well as enrichment analysis of gene sets were carried out for ABI3BP co-expression via R package. And finally we explored the relation of expression of ABI3BP and lung tumor immunity invasion, exploring the influence of ABI3BP level of expression on immunotreatment and whether immunity invasion would affect the prognosis of patients with lung tumor. Results: ABI3BP is downregulated in LUAD and LUSC, and associated to lung tumor phase and prognosis. Univariate and multivariate cox regression showed that ABI3BP was an independent prognostic factor in patients with lung tumors. The extracellular matrix protein-coding gene and the ABI3BP-related gene were intersected to obtain 10 hub genes. On the basis of GO/KEGG enrichment analysis, hub genes are closely associated to immunity-associated pathways including T cell receptor signaling pathway, immune response−activating cell surface receptor signaling pathway. Finally, the expression of ABI3BP is closely related to immune cell infiltration and immune cell marker set, and the expression of ABI3BP can help predict the therapeutic effect of immune checkpoint inhibitors and improve the prognosis of patients. Conclusion: ABI3BP could be a new target for lung tumor that could be utilized as a diagnostic and therapeutic tool.

[1]  E. Pikarsky,et al.  Vav1 accelerates Ras-driven lung cancer and modulates its tumor microenvironment. , 2022, Cellular signalling.

[2]  Zhaohui S. Qin,et al.  UALCAN: An update to the integrated cancer data analysis platform , 2022, Neoplasia.

[3]  L. Nie,et al.  LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients , 2021, Frontiers in Cell and Developmental Biology.

[4]  Yangchun Feng,et al.  Lymphocyte cytosolic protein 2 is a novel prognostic marker in lung adenocarcinoma , 2021, The Journal of international medical research.

[5]  A. Lánczky,et al.  Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation , 2021, Journal of medical Internet research.

[6]  Lin Zhou,et al.  Extracellular matrix and its therapeutic potential for cancer treatment , 2021, Signal Transduction and Targeted Therapy.

[7]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[8]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[9]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[10]  Caicun Zhou,et al.  The cutting-edge progress of immune-checkpoint blockade in lung cancer , 2020, Cellular & Molecular Immunology.

[11]  Tianyu Lu,et al.  The Depletion of ABI3BP by MicroRNA-183 Promotes the Development of Esophageal Carcinoma , 2020, Mediators of inflammation.

[12]  Beibei Ru,et al.  TISIDB: an integrated repository portal for tumor-immune system interactions , 2019, Bioinform..

[13]  N. Lin,et al.  Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells , 2019, Journal of experimental & clinical cancer research : CR.

[14]  Dawn A. Delfín,et al.  The Extracellular Matrix Protein ABI3BP in Cardiovascular Health and Disease , 2019, Front. Cardiovasc. Med..

[15]  C. Lin,et al.  Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities. , 2018, Chest.

[16]  M. Hauser,et al.  A genome-wide association study of suicide attempts and suicidal ideation in U.S. military veterans , 2018, Psychiatry Research.

[17]  A. E. del Río Hernández,et al.  Role of Extracellular Matrix in Development and Cancer Progression , 2018, International journal of molecular sciences.

[18]  Jun S. Liu,et al.  TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. , 2017, Cancer research.

[19]  E. Savolainen,et al.  Intrauterine growth restriction and placental gene expression in severe preeclampsia, comparing early-onset and late-onset forms , 2017, Journal of perinatal medicine.

[20]  Neil J Kelly,et al.  Variable Susceptibility to Cigarette Smoke‐Induced Emphysema in 34 Inbred Strains of Mice Implicates Abi3bp in Emphysema Susceptibility , 2017, American journal of respiratory cell and molecular biology.

[21]  C. Lindskog,et al.  A pathology atlas of the human cancer transcriptome , 2017, Science.

[22]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[23]  A. Kilic,et al.  Altered protein levels in the isolated extracellular matrix of failing human hearts with dilated cardiomyopathy. , 2017, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[24]  Tsippi Iny Stein,et al.  The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses , 2016, Current protocols in bioinformatics.

[25]  S. Gabriel,et al.  Genomic correlates of response to CTLA-4 blockade in metastatic melanoma , 2015, Science.

[26]  Kwok-Kin Wong,et al.  Non-small-cell lung cancers: a heterogeneous set of diseases , 2014, Nature Reviews Cancer.

[27]  A. Whetton,et al.  The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. , 2014, Cancer treatment reviews.

[28]  Michael G. Christel,et al.  Genome-Wide Association Study of Suicide Attempts in Mood Disorder Patients , 2010 .

[29]  G. Riggins,et al.  Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion. , 2008, Endocrine-related cancer.

[30]  Jeremy J. W. Chen,et al.  A five-gene signature and clinical outcome in non-small-cell lung cancer. , 2007, The New England journal of medicine.

[31]  M. Maruyama,et al.  Expression of TARSH gene in MEFs senescence and its potential implication in human lung cancer. , 2005, Biochemical and biophysical research communications.

[32]  S. Matsuda,et al.  Cloning and sequencing of a novel human gene that encodes a putative target protein of Nesh-SH3 , 2001, Journal of Human Genetics.